Citation Impact
Citing Papers
Immune Rejection of Mouse Tumors Expressing Mutated Self
2009 StandoutNobel
A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression
2005 StandoutNobel
MRE11 Expression Is Predictive of Cause-Specific Survival following Radical Radiotherapy for Muscle-Invasive Bladder Cancer
2010
Accurate Reconstruction of the Temporal Order of Mutations in Neoplastic Progression
2011
Chapter 4 Preparation of Isolated Rat Liver Cells
1976 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
Occurrence of the potent mutagens 2- nitrobenzanthrone and 3-nitrobenzanthrone in fine airborne particles
2019 Standout
DNA adduct burden and tobacco carcinogenesis
2002
Increased Expression of RelA/Nuclear Factor-κB Protein Correlates with Colorectal Tumorigenesis
2003
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
2004 Standout
Chemosensitivity linked to p73 function
2003 StandoutNobel
Base-excision repair of oxidative DNA damage
2007 StandoutNature
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
The health consequences of smoking: Cancer
1992
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
2008 Standout
Oxidative damage to DNA: Formation, measurement, and biological significance
1997
A view on drug resistance in cancer
2019 StandoutNature
Microsatellite Instability in Colorectal Cancer
2010 Standout
Potency Equivalency Factors for Some Polycyclic Aromatic Hydrocarbons and Polycyclic Aromatic Hydrocarbon Derivatives
1998
The DNA Damage Response Kinases DNA-dependent Protein Kinase (DNA-PK) and Ataxia Telangiectasia Mutated (ATM) Are Stimulated by Bulky Adduct-containing DNA
2011 StandoutNobel
p53 codon 72 polymorphism and its association with bladder cancer
2002
Mutagenicity of anticancer drugs in mammalian germ cells
1996
Head and neck cancer
2008 Standout
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
2005 StandoutNature
The mini-driver model of polygenic cancer evolution
2015 StandoutNobel
Activating K-Ras mutations outwith ‘hotspot’ codons in sporadic colorectal tumours – implications for personalised cancer medicine
2010
HIF-1α Induces Genetic Instability by Transcriptionally Downregulating MutSα Expression
2005 StandoutNobel
The Breast Cancer Susceptibility Gene BRCA1 Is Required for Subnuclear Assembly of Rad51 and Survival following Treatment with the DNA Cross-linking Agent Cisplatin
2000
Data processing, multi-omic pathway mapping, and metabolite activity analysis using XCMS Online
2018
Colorectal cancer
2013 Standout
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
2010 StandoutNature
Cigarette smoking induces an increase in oxidative DNA damage, 8- hydroxydeoxyguanosine, in a central site of the human lung
1997
Cancer genes and the pathways they control
2004 Standout
DNA Damage, Aging, and Cancer
2009 Standout
Classification of colorectal cancer based on correlation of clinical, morphological and molecular features
2006
Multiple ATR-Chk1 Pathway Proteins Preferentially Associate with Checkpoint-Inducing DNA Substrates
2011 StandoutNobel
Oxidative Stress, Chromatin Remodeling and Gene Transcription in Inflammation and Chronic Lung Diseases
2003
High Fragmentation Characterizes Tumour-Derived Circulating DNA
2011
The DNA Damage Response: Making It Safe to Play with Knives
2010 Standout
Lung Cancer Patients Have Increased 8‐Hydroxydeoxyguanosine Levels in Peripheral Lung Tissue DNA
1998
The Larger Acenes: Versatile Organic Semiconductors
2007 Standout
Bladder cancer
2016 Standout
Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas
2003
Expression of activation-induced cytidine deaminase in human hepatocytes via NF-κB signaling
2007 StandoutNobel
Genome maintenance mechanisms for preventing cancer
2001 StandoutNature
The DNA damage response and cancer therapy
2012 Nature
Mutational Heterogeneity in Human Cancers: Origin and Consequences
2009
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
Noninvasive measures of oxidative stress status in humans
1991
DNA damage metabolism and aging
1990
Molecular epidemiology of human cancer risk: gene-environment interactions andp53 mutation spectrum in human lung cancer
1999
Clonal evolution in cancer
2012 StandoutNature
Biaryl Phosphane Ligands in Palladium‐Catalyzed Amination
2008 Standout
The Hallmarks of Aging
2013 Standout
Engineering domain fusion chimeras from I-OnuI family LAGLIDADG homing endonucleases
2012 StandoutNobel
Cancer-related inflammation
2008 StandoutNature
Wnt signalling in stem cells and cancer
2005 StandoutNature
Cancer as an evolutionary and ecological process
2006 Standout
Destructive cycles: the role of genomic instability and adaptation in carcinogenesis
2004
Tumour evolution inferred by single-cell sequencing
2011 StandoutNature
Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations
2004
DNA damage induced by cigarette smoke condensate in vitro as assayed by 32P-postlabeling. Comparison with cigarette smoke-associated DNA adduct profiles in vivo
1992
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
Preservation of Fertility in Patients with Cancer
2009 Standout
Clonality Assessment and Clonal Ordering of Individual Neoplastic Crypts Shows Polyclonality of Colorectal Adenomas
2010
The cancer genome
2009 StandoutNature
Vascular damage from smoking: disease mechanisms at the arterial wall
1998
Structure of DNA polymerase β with a benzo[ c ]phenanthrene diol epoxide-adducted template exhibits mutagenic features
2006
Advances in Chemical Carcinogenesis: A Historical Review and Prospective
2008
The Free Radical Theory of Aging Matures
1998 Standout
A Computational Study of the Hydrolysis of dGTP Analogues with Halomethylene-Modified Leaving Groups in Solution: Implications for the Mechanism of DNA Polymerases
2009 StandoutNobel
Deficiencies in Mouse Myh and Ogg1 Result in Tumor Predisposition and G to T Mutations in Codon 12 of the K-Ras Oncogene in Lung Tumors
2004 StandoutNobel
Methylated purines in the deoxyribonucleic acid of various Syrian-golden-hamster tissues after administration of a hepatocarcinogenic dose of dimethylnitrosamine
1976
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Human cancers express a mutator phenotype
2006
A specific spectrum of p53 mutations in lung cancer from smokers: review of mutations compiled in the IARC p53 database.
1998
Induction of a DNA glycosylase for N-methylated purines is part of the adaptive response to alkylating agents
1982 StandoutNatureNobel
The effects of charcoal-broiled meat consumption on antioxidant defense system of erythrocytes and antioxidant vitamins in plasma
2004
Microsatellite instability in colorectal cancer
2006
Liquid Biopsies: Genotyping Circulating Tumor DNA
2014 Standout
Addictive Drugs: The Cigarette Experience
1992 StandoutScienceNobel
Colorectal cancer: molecular features and clinical opportunities.
2010
Synthesis of the C8-Deoxyguanosine Adduct of the Food Mutagen IQ
2001
SIGNALING PATHWAYS IN INTESTINAL DEVELOPMENT AND CANCER
2004
Cancers Exhibit a Mutator Phenotype: Clinical Implications
2008
Exposure to anticancer drugs can result in transgenerational genomic instability in mice
2012
MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights
2021 Standout
Multiple mutations and cancer
2003
Cholangiocytes express the aquaporin CHIP and transport water via a channel-mediated mechanism.
1994 StandoutNobel
Works of R.C. Garner being referenced
The role of DNA adducts in chemical carcinogenesis
1998
Correlation of DNA adduct levels in human lung with cigarette smoking
1988 Nature
Cyclophosphamide: Review of its mutagenicity for an assessment of potential germ cell risks
1995
The use of purified DNA repair proteins to detect DNA damage
1994
Comparative lung tumorigenicity of parent and mononitro-polynuclear aromatic hydrocarbons in the BLU:Ha newborn mouse assay
1989
Chemical Carcinogenesis Essays
1975
Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancer
2002
A hot spot for p53 mutation in transitional cell carcinoma of the bladder: clues to the etiology of bladder cancer.
1997